Debbie Merrithew [mailto:]

Transcription

Debbie Merrithew [mailto:]
From: Debbie Merrithew [mailto:[email protected]]
Sent: November 4, 2015 7:03 AM
To: Debbie Merrithew <[email protected]>
Subject: Notice: Health Canada Requirements for Manufacturers Relating to Manufacturing Change to
Tyvek® 1073B and 1059B Avis: Exigences de Santé Canada à l'égard des fabricants liées à la modification
de la fabrication de Tyvek® 1073B et 1059B
Notice: Health Canada Requirements for Manufacturers Relating to Manufacturing Change to
Tyvek® 1073B and 1059B
http://www.hc-sc.gc.ca/dhp-mps/md-im/activit/announce-annonce/tyvek_notice_avis-eng.php
Avis: Exigences de Santé Canada à l'égard des fabricants liées à la modification de la fabrication
de Tyvek® 1073B et 1059B
http://www.hc-sc.gc.ca/dhp-mps/md-im/activit/announce-annonce/tyvek_notice_avis-fra.php
From: Valerie Delorme [mailto:[email protected]]
Sent: November 6, 2015 11:25 AM
To: Valerie Delorme <[email protected]>
Subject: Notice: Updates to the Guidance Document: Fees for the Review of Drug Submissions and
Applications Avis : Mises a jour a la Ligne directrice - Frais pour l'examen des presentations et de
demandes de drogue
http://www.hc-sc.gc.ca/dhp-mps/prodpharma/activit/announce-annonce/notice_fee_frais_guide_aviseng.php
http://www.hc-sc.gc.ca/dhp-mps/prodpharma/activit/announce-annonce/notice_fee_frais_guide_avisfra.php
From: Debbie Merrithew [mailto:[email protected]]
Sent: November 16, 2015 1:10 PM
To: Debbie Merrithew <[email protected]>
Subject: Health Canada: Notice: Antimicrobials Product Labelling Santé Canada: Avis : L'étiquetage des
produit pour antimicrobiens
November 16, 2015
Health Canada: Notice: Antimicrobials Product Labelling
http://www.hc-sc.gc.ca/dhp-mps/prodpharma/activit/announce-annonce/notice-amr-avis-ram-eng.php
Le 16 novembre 2015
Santé Canada: Avis : L'étiquetage des produit pour antimicrobiens
http://www.hc-sc.gc.ca/dhp-mps/prodpharma/activit/announce-annonce/notice-amr-avis-ram-fra.php
From: Valerie Delorme [mailto:[email protected]]
Sent: November 23, 2015 6:26 AM
To: Valerie Delorme <[email protected]>
Subject: Update: Implementation of Plain Language Revisions to Part III: Patient Medication Information
and Associated Templates of the Guidance Document: Product Monograph Mise a jour : Mise en ouvre
des revisions en langage clair de la partie III des Renseigneme
http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/monograph/notice_pmi_aviseng.php
http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/monograph/notice_pmi_avisfra.php
From: Debbie Merrithew [mailto:[email protected]]
Sent: November 25, 2015 1:49 PM
To: Debbie Merrithew <[email protected]>
Subject: Consultation : Release of Draft (Step 2) International Council on Harmonisation of Technical
Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance: E6 Integrated
Addendum: Good Clinical Practice Consultation : Publication de l'
The above referenced draft guidance was released by the ICH Steering Committee for consultation and
is being posted on the Health Canada website for information and comment in accordance with Step 2
of the ICH process.
This consultation is open for comment starting November 25, 2015 until February 1, 2016.
http://www.hc-sc.gc.ca/dhp-mps/consultation/drug-medic/consult-e6-add-step2etape-eng.php
La ligne directrice susmentionnée a été publiée par le comité directeur de l'ICH à des fins de
consultation et est publiée sur le site Web de Santé Canada à titre d'information et en vue de recueillir
des commentaires conformément à l'étape 2 du processus de l'ICH.
Cette consultation est disponible pour vos commentaires du 25 novembre 2015 au 1 février 2016.
http://www.hc-sc.gc.ca/dhp-mps/consultation/drug-medic/consult-e6-add-step2etape-fra.php